Skip to Main Content

An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus

Conditions

Diseases of the Musculoskeletal System

Phase II

What is the purpose of this trial?

Brief Summary:

This study will investigate BMS-986165 to assess its effects in patients with systemic lupus erythematosus (SLE).

  • Trial with
    Bristol-Myers Squibb Research and Development
  • Start Date
    02/04/2019
  • End Date
    07/19/2020
Trial Image

For more information about this study, contact:

Allison Ready

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/15/2019
  • Study HIC
    #2000023756